U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07003425) titled 'A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis' on May 26.
Brief Summary: This is a multicenter, double-blind, Long-Term Extension (LTE) study to evaluate the long-term safety and efficacy of APG777 in patients with moderate-to-severe AD who have completed treatment in an APG777 Parent Study (NCT06395948).
The LTE study will consist of 3 periods: 1) Screening Visit will coincide with the last visit of the Maintenance Period in the Parent Study 2) Extended Treatment Period 3) Post-treatment Follow-up Period.
This study will be conducted in participants with atopic dermatitis (AD) who completed the Treat...